KMKirill M. Mikhaylov

Kirill M. Mikhaylov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kirill M. Mikhaylov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hyperuricemia and osteoarthritis: Aspects of immunobiochemical interaction

    by A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. M. Savushkina, E. A. Strebkova, N. G. Kashevarova, A. R. Khalmetova, D. M. Kudinsky, K. M. Mikhaylov, A. S. Avdeeva, et al.

    The aim of this single‑center study was to investigate the relationship between hyperuricemia (HU) and biochemical and immunological parameters in patients with knee osteoarthritis (KOA). Materials and methods . The study included 255 patients aged 40–75 years with a confirmed diagnosis of KOA, Kellgren – Lawrence radiological stages I–III, who provided informed consent. The mean age of the patients was 53.0±10.5 years, body mass index (BMI) was 28.8±6.7 kg/m 2 , and the median disease duration was 2 [0.8; 7] years. The following assessments were performed: questionnaire survey, laboratory testing, standard radiography, knee ultrasound, magnetic resonance imaging (MRI) of the target joint, and dual-energy X‑ray absorptiometry of the axial skeleton. Results . HU was detected in 16.9 % of cases. These patients exhibited significantly higher values ( p < 0.05 in all cases) for: pain on the visual analogue scale, total WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, including all its components, and general health status, as well as worse scores on the KOOS (Knee injury and Osteoarthritis Outcome Score), compared with participants without HU. Furthermore, elevated uric acid levels were significantly associated with higher incidence of synovitis, neuropathic pain component, advanced radiological stages, and more severe joint structural damage on MRI (WORMS (WholeOrgan Magnetic Resonance Imaging Score)). However, after adjusting for BMI and waist circumference (WC), these differences lost statistical significance. At the same time, patients with HU showed higher bone mineral density values in the proximal femur and a higher prevalence of coronary artery disease. Additionally, associations were found with higher levels of triglycerides, creatinine, alkaline phosphatase, and lower levels of high-density lipoprotein ( p < 0.05 in all cases). No associations were found with pro- and anti-inflammatory cytokines (interleukin (IL) 1β, IL-6, IL-10, IL-34), metalloproteinase (MMP) 3, MMP-9, markers of cartilage and bone tissue degradation (CTX-I, CTX-II, COMP), or C‑reactive protein. Conclusion . The relationship between HU and KOA severity is most likely indirect and is determined by excess body weight and visceral obesity (as indicated by WC). The lack of associations between HU and CRP levels, pro‑inflammatory cytokines, and cartilage degradation markers suggests that uric acid does not have a direct effect on these parameters in patients with KOA.

  • Open Access

    Relationship between vitamin D and osteoarthritis

    by N G Kashevarova, L I Alekseeva, E A Taskina, E A Strebkova, E P Sharapova, N M Savushkina, K M Mikhaylov, S I Glukhova, O G Alekseeva, D M Kudinsky, et al.

    Background. Osteoarthritis (OA) is a common joint disease and one of the leading causes of disability worldwide. The role of vitamin D in the etiology and development of OA is still unclear, but it may be important for both diagnosis and timely therapy. Aim. To evaluate the relationship of vitamin D levels with clinical and instrumental parameters in OA in a cross-sectional study. Materials and methods. The study included 171 patients aged 40–75 with confirmed knee OA according to the American College of Rheumatology (ACR) classification, stage I–III (according to Kellgren and Lawrence). All patients signed informed consent. The mean age was 53.5±9.94 years, body mass index (BMI) was 29.8±6.4 kg/m2, and disease duration was 3 [1; 7] years. For each patient, a case record form was filled out, including anthropometric indicators, medical history, clinical examination data, an assessment of knee joint pain according to the Visual Analog Scale (VAS), WOMAC, and the patient's general health condition (PGHC). All patients underwent standard radiography, knee ultrasound examination and magnetic resonance imaging (MRI) (WORMS), densitometry of the lumbar spine and femoral neck, and laboratory tests. Statistical processing of the data was performed using the Statistica 10 software. Results. Normal vitamin D values (≥30 ng/mL) were found in 62 (36.3%) patients, low levels (30 ng/mL) in 109 (63.7%) patients, insufficiency (30 ng/mL and 20 ng/mL) in 66 (38.6%) patients, and deficiency (20 ng/mL) in 43 (25.1%). Patients were divided into three groups according to the presence or absence of vitamin D insufficiency/deficiency: Group 1 included patients with normal vitamin D levels, Group 2 included patients with insufficiency, and Group 3 included patients with vitamin D deficiency. Patients of the three groups were comparable in age and disease duration but differed significantly in body weight, BMI, and waist measurement (higher in groups with reduced vitamin D values; p0.05). Also, these patients had significantly higher VAS pain scores, total WOMAC and its components (pain, stiffness, and dysfunction), PGHC, and worse KOOS. More patients in Groups 2 and 3 had OA of the hip and hand joints, clinically detected synovitis, flat feet, and quadriceps muscle hypotrophy. Ultrasound examination significantly more often revealed a reduction of cartilage tissue on both the anteromedial and anterolateral surfaces of the knee joint; MRI showed more often osteitis in the medial condyles of the femur and tibia (p0.05 for all values). Conclusion. Our study demonstrated that low blood vitamin D levels (insufficiency/deficiency) were associated with a more severe knee OA. These patients had a large body weight, BMI, higher VAS pain values, WOMAC index (overall and its components), worse KOOS, PGHC, and smaller cartilage sizes in the medial parts of the knee joint (according to ultrasound); such patients were significantly more likely to have osteitis in the medial parts of the femur and tibia according to MRI. Also, stage II and III knee OA and OA of other localizations, clinically detected synovitis, quadriceps hypotrophy, and flat feet were more common.


  • Open Access

    Clinical and instrumental characteristics of osteoarthritis in hyperuricemia

    by E. A. Taskina, A. M. Lila, L. I. Alekseeva, N. G. Kashevarova, K. M. Mikhailov, А. Р. Хальметова, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, D. M. Kudinskiy, et al.

    Objective: to investigate in a multicentre single-stage study the relationships between hyperuricemia (HU) and clinical, instrumental and laboratory parameters of osteoarthritis (OA).Material and methods. The study included 200 patients aged 40 to 75 years with a definite diagnosis of knee (KN) OA that met ACR criteria, with stage I–III OA by Kellgren–Lawrence. The mean age of the patients was 55.9±10.3 years and the body mass index (BMI) was 29.4±6.2 kg/m2. An individual chart was completed for each patient, including anthropometric parameters, medical history and clinical examination data, visual analogue scale (VAS) assessment of KN pain, WOMAC, patient's general health assessment (GHA) and information on comorbidities. All patients underwent standard radiography and magnetic resonance imaging (MRI) of the KN (WORMS), dual-energy X-ray absorptiometry of the lumbar spine and femoral neck, and laboratory examination.Results and discussion. HU was diagnosed in 57 (28.5) patients when the serum uric acid (UA) level was above 360 μmol/L. Patients were divided into two groups according to the presence or absence of HU. The age of the patients in the two groups was comparable, but they differed significantly in terms of disease duration, BMI, waist and hip circumference, which were greater in the HU group (p Conclusion. At high UA levels, pain values according to VAS and WOMAC are higher, GHA is worse, and CRP and COMP levels are elevated. MRI shows more frequent osteitis in the medial aspect of the tibia in patients with HU. Deciphering the mechanisms that determine the relationship between HU and OA is important for the development of new methods for the prevention and treatment of these diseases.


  • Open Access

    The influence of type 2 diabetes mellitus on clinical manifestations of osteoarthritis

    by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, K. M. Mikhailov, T. A. Raskina, I. B. Vinogradova, E. N. Otteva, et al.

    Objective: to investigate in a multicenter study relationship between type 2 diabetes mellitus (DM) and clinical manifestations of osteoarthritis (OA). Material and methods. The study involved 767 patients aged 40–75 years with a confirmed diagnosis of stage I–III knee OA who had signed an informed consent form. The mean age of patients was 57.9±9.6 years, body mass index (BMI) was 30.8±6.4 kg/m2 and median duration of disease was 5 [2; 11] years. An individual record card was filled out for each patient, it contained anthropometric parameters, medical history and clinical examination data, knee pain assessment using a visual analogue scale (VAS), WOMAC, parameters of KOOS questionnaire and patient's global assessment of health. Results and discussion. DM was detected in 17.2% of cases. Patients were categorized into two groups according to the presence or absence of DM. In the presence of DM, more severe clinical manifestations of OA were noted. However, patients with DM were older, had higher BMI values, longer disease duration and were more frequently diagnosed with radiological stage III OA. After stratification by age and disease duration, individuals with DM retained worse pain scores according to VAS compared to patients without DM (median 51.5 [41.5; 70] mm versus 36 [25; 50] mm, p=0.049), total WOMAC index (1047.5 [792; 1260] mm versus 823 [536; 1145] mm; p=0.005) and its components (pain – 200 [160; 254] mm versus 155 [108; 230] mm, p=0.002; stiffness – 90 [50; 115] mm versus 60.5 [35; 100] mm, p=0.03; functional impairment – 765 [550; 918] mm versus 595 [350; 820] mm, p=0.009). Conclusion. Type 2 DM is common in patients with OA (in 17.2% of cases) and is associated with more severe clinical manifestations: greater pain intensity according to VAS and higher WOMAC scores (total index and its components).


  • Open Access

    Relationship between hypercholesterolemia and osteoarthritis (preliminary results)

    by Elena A. Taskina, Liudmila I. Alekseeva, Natalia G. Kashevarova, Ekaterina A. Strebkova, Kirill M. Mikhaylov, Evgeniia P. Sharapova, Natalya M. Savushkina, Olga G. Alekseeva, Tatiana A. Raskina, Julia V. Averkieva, et al.

    Aim. To evaluate the relationship of hypercholesterolemia (HCE) with clinical, instrumental, and laboratory parameters in osteoarthritis (OA) in a multicenter, cross-sectional study. Materials and methods. The study included 183 patients aged 40–75 years, with a confirmed diagnosis of stage I–III OA (ACR) of the knee joints, who signed an informed consent. The mean age was 55.6±10.7 years (40 to 75), body mass index was 29.3±6.3 kg/m2, and disease duration was 5 [1; 10] years. For each patient, a case record form was filled out, including anthropometric indicators, medical history, clinical examination data, an assessment of knee joint pain according to VAS, WOMAC, KOOS and comorbidities. All patients underwent standard radiography and ultrasound examination of the knee joints and laboratory tests. Results. HCE was detected in 59% of patients. Depending on its presence or absence, patients were divided into two groups. Patients were comparable in body mass index, waist and hip measurement, and disease duration but differed significantly in age. Individuals with elevated total cholesterol levels had higher VAS pain scores, total WOMAC and its components, an overall assessment of the patient's health, a worse KOOS index, and ultrasound findings (reduced cartilage tissue). HCE patients showed high levels of cholesterol, low-density lipoproteins, triglycerides, STX-II, and COMP (p0.05). However, after stratification by age, many initial intergroup differences became insignificant, and differences in the WOMAC pain score persisted. Conclusion. The results of the study confirmed the high prevalence of HCE in OA patients (59%). Patients with OA and increased total cholesterol have more intense pain in the knee joints.